Type I interferon pathway in adult and juvenile dermatomyositis.
about
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesType I interferon blockade in systemic lupus erythematosus: where do we stand?Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis.Regulatory effects of SKAR in interferon α signaling and its role in the generation of type I IFN responses.Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damageBorrelia burgdorferi induces a type I interferon response during early stages of disseminated infection in mice.Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological ResponsesCardiovascular risk in pediatric-onset rheumatological diseases.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Fueling autoimmunity: type I interferon in autoimmune diseases.Diagnosis, pathogenesis and treatment of myositis: recent advances.New age of biological therapies in paediatric rheumatology.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.Republished: new age of biological therapies in paediatric rheumatology.Current pharmacological treatment of idiopathic inflammatory myopathies.The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses.Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases.Causes and consequences of endoplasmic reticulum stress in rheumatic disease.[Dermatomyositis-update].Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis.IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models.Aminoquinoline antimalarial therapy in dermatomyositis-are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity?Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases.CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α.
P2860
Q26798209-9C9B4019-819B-423F-BE25-BB7929B0265FQ26865441-82532E2F-70F7-42B2-A94E-95E6C930C253Q33956662-1D815D67-CCAF-4D90-A2F9-ACD750D94FE2Q34025462-9833E983-9FA9-439A-8A43-CC4D14578872Q35125063-A5AF7D81-0909-45A8-AF3F-509320C93B26Q35950343-3CBFD25D-EB05-4F49-8384-59E350EE03E3Q36291269-27CC3715-B8BC-4201-8B41-802154B94255Q36518337-0844FC4E-791D-4389-8405-F65A5E3DF452Q36903089-194FDED9-50A2-4AB6-AA26-C2191D5A0B42Q37368405-F82ADB4C-CA70-498D-96A1-DE7E25C7D4AEQ37416120-D8D5FF4D-6662-48B5-99D9-6C7BADFEC465Q38131849-E94EEA32-6188-485B-B8D1-8A1F3CF9B98DQ38195363-807CE4AB-3502-4F89-96B0-BEA849DCD1B1Q38221095-3D94C613-7D07-469A-AEC0-AC6B3631F510Q38244567-32DD3902-817E-4977-A84C-BA1FDE1139D8Q38248819-3CFA4DFD-5936-43EF-8B4E-E8941B238677Q38250593-12565050-A710-472C-B5A4-46E652777432Q38680762-61CFCB36-A103-4E42-A29B-F3F6DC27C23CQ38700961-46967930-2F23-48AF-A06C-36A66FBFF3B1Q38717418-12A249A1-F156-4901-8794-81F9D247B75AQ38853161-12EBC403-B757-4309-BF14-A30F53D202F4Q39025066-27925A88-9DD4-41B8-9B0A-67B6321590EBQ41085880-70ED34C1-3F05-4C29-A4D1-0A2609368C44Q41192731-3F040819-7C04-45B0-81E5-641C1D49DD6CQ47781790-41CEFB54-9223-47FC-9431-72DC1E2B4A1BQ50224678-C9F17633-C350-4C9F-9981-A118F64D24DBQ52655916-88A87CD7-8C7C-40F5-BD2C-4AAFADDB2DAFQ55053285-7B145E35-DB26-4F88-870B-47448B9B3A67Q55383884-55B90232-3547-41FA-A829-83A933BA0AF6Q55487166-A0436D44-A9ED-4CD7-9CD8-3614A3E4B414
P2860
Type I interferon pathway in adult and juvenile dermatomyositis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Type I interferon pathway in adult and juvenile dermatomyositis.
@ast
Type I interferon pathway in adult and juvenile dermatomyositis.
@en
type
label
Type I interferon pathway in adult and juvenile dermatomyositis.
@ast
Type I interferon pathway in adult and juvenile dermatomyositis.
@en
prefLabel
Type I interferon pathway in adult and juvenile dermatomyositis.
@ast
Type I interferon pathway in adult and juvenile dermatomyositis.
@en
P2093
P2860
P356
P1476
Type I interferon pathway in adult and juvenile dermatomyositis.
@en
P2093
Ann M Reed
Emily C Baechler
Hatice Bilgic
P2860
P2888
P356
10.1186/AR3531
P577
2011-12-22T00:00:00Z
P5875
P6179
1001147453